Circadian Rhythm Impact on TNBC Response to Neoadjuvant Immunotherapy

Clinical trial NCT06880029 · RECRUITING

Trial details

NCT number: NCT06880029
Sponsor: Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Triple Negative Breast Cancer (TNBC)

Start date: 2024-09-01
Primary completion: 2025-09-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.